Cancer under age 50 increased 80% from 1990 to 2019

Original Article ↗ Hacker News Discussion ↗

An oncology study reporting an 80% rise in global cancer cases under age 50 from 1990 to 2019 prompts scrutiny of how the numbers are presented. Commenters highlight that the headline figure reflects absolute case counts without adjusting for population growth, while age‑standardized incidence is roughly flat and mortality has declined, likely due to earlier detection and better treatment. Debate centers on the relative roles of improved diagnostics, lifestyle and diet, and environmental pollution, with concern over sensationalized statistics obscuring the more nuanced picture of changing cancer risk.

Study framing & headline concerns

  • Several commenters note the headline “80% increase” uses absolute case counts, not population-adjusted rates.
  • Population in key age bands (15–49 and especially 40–49) grew substantially over the period, which could explain much of the raw increase.
  • Responses cited in the journal argue: age-specific and age-standardized incidence and mortality show no clear increase since the mid‑1990s, while mortality has declined.
  • Some call this “bad science communication” and a failure by editors for allowing a headline anchored on absolute numbers.

Incidence vs mortality & treatment

  • Figures in the paper show early-onset cancer deaths rising modestly (~800k to ~1M) while population grew faster, suggesting per‑capita mortality is flat or down.
  • Age-adjusted death rates reportedly decreased “dramatically” for both genders, while incidence rates rose only marginally.
  • Many infer: increased detection and improved treatment are the main drivers, not necessarily a surge in underlying disease risk.
  • Others caution that earlier detection lowering mortality doesn’t by itself prove incidence hasn’t increased.

Geographic patterns & development

  • Map/figure discussions note large incidence increases in parts of South America and Africa, with flat or declining rates in many high‑income countries.
  • Explanations offered:
    • Better access to healthcare and diagnostics in developing regions revealing previously undiagnosed cancers.
    • Fewer deaths from infectious disease and malnutrition, so more people live long enough to get diagnosed with cancer.
    • Industrialization, pollution, and dietary shifts toward “Western” or ultra‑processed foods.

Environment, lifestyle, and risk factors

  • Multiple comments worry about plastics, microplastics, PFAS, trash burning, pesticides, and industrial pollution, invoking the precautionary principle.
  • Others counter that many pollution measures in the West have improved and that media (and this study’s framing) can exaggerate risk perceptions.
  • The paper’s own conclusion (as quoted) emphasizes diet (red meat, low fruit/milk, high sodium), alcohol, and tobacco as main modifiable risk factors, and advocates healthier lifestyles.

Medicine, prevention, and broader skepticism

  • Some see frustratingly slow progress in cancer cures; others are optimistic about a shift from “science” to “engineering” in biomedicine (PCR, mRNA).
  • Several threads debate overdiagnosis, screening, antibiotic overuse, autoimmunity, and trust in doctors and pharmaceuticals.
  • A minority raise unsubstantiated links (e.g., RF exposure, COVID vaccines) as possible contributors; these claims are not resolved within the discussion.